iSpecimen Inc.
ISPCNASDAQHealthcare● Active
$2.95
$-0.07(-2.32%)
Market Cap$409643
P/E Ratio—
52W High$127.2
52W Low$2.9
iSpecimen Inc.（ISPC）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · ISPC · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($10.49M) | ($12.50M) | ($11.10M) | ($10.25M) | ($8.96M) |
| Depreciation & Amort. | $1.66M | $2.29M | $2.12M | $1.21M | $1.00M |
| Stock-Based Comp. | $0.02M | $0.25M | $0.46M | $0.68M | $0.62M |
| Change in Working Capital | $2.11M | ($0.50M) | $2.59M | $2.35M | ($5.28M) |
| Net Cash from Operations | ($4.24M) | ($8.26M) | ($5.81M) | ($5.82M) | ($10.67M) |
| Investing Activities | |||||
| Capital Expenditure | ($0.00M) | ($0.06M) | ($4.74M) | ($3.19M) | ($1.04M) |
| Purchases of Investments | $4.00M | ($0.46M) | ($13.04M) | $0.00M | $0.00M |
| Sales of Investments | $0.00M | $3.15M | $10.56M | $0.00M | $0.00M |
| Net Cash from Investing | ($1.00M) | $1.98M | ($7.23M) | ($3.19M) | ($1.04M) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Dividends Paid | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Debt Issued / Repaid | $0.00M | $0.00M | $0.00M | ($3.50M) | $1.00M |
| Net Cash from Financing | $10.24M | $5.82M | $0.07M | ($3.42M) | $38.75M |
| Free Cash Flow | |||||
| Free Cash Flow | ($4.24M) | ($8.30M) | ($10.55M) | ($9.01M) | ($11.71M) |
| FCF Margin %(computed) | -219.86% | -89.28% | -106.28% | -86.60% | -105.13% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · M
深入了解iSpecimen Inc.
关于iSpecimen Inc.（ISPC）现金流量表
iSpecimen Inc. 2025财年经营活动现金流($0.00B)，自由现金流($0.00B)（FCF利润率-219.86%），资本支出($0.00B)。
常见问题
ISPC · 4 问iSpecimen Inc. 2025财年自由现金流($0.00B)，同比up48.9%。
ISPC free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10